Clinical Trial Update: Topically Applied Bisphosphocin Nu-3 on Infected Diabetic Ulcers of Subjects With Type I or II Diabetes Mellitus [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating topically applied bisphosphocin Nu-3 for infected diabetic ulcers in adults with diabetes; study completed with posted resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Diabetic Foot Infection

Drugs mentioned

• Nu-3 (bisphosphocin)

Snippet

Sponsor: Lakewood-Amedex Inc | Conditions: Diabetic Foot Infections | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-11-19